Investors could be interested in the following securities, as their forward price-earnings ratios are lower than the S&P 500's historical average price-earnings ratio of 15. The projections of future earnings are based on data from Morningstar analysts.
Criteo SA
The first stock that makes the cut is Criteo SA (CRTO, Financial), a developer of customized advertisements for online retailers in France and internationally.
Criteo SA has a forward price-earnings ratio of 14.47, which results from Monday’s closing price of $42.13 per share and analyst expectations for net earnings per share of approximately $2.91 for the next full fiscal year.
The stock has risen 132% over the past year for a market capitalization of $2.56 billion and a 52-week range of $17.04 to $46.65.
GuruFocus has assigned a rating of 8 out of 10 for the company's financial strength and a rating of 7 out of 10 for its profitability.
Wall Street sell-side analysts recommend a median rating of overweight for this stock with an average price target of $52.17 per share.
Great Western Bancorp Inc
The second stock that qualifies is Great Western Bancorp Inc (GWB, Financial), a Sioux Falls, South Dakota-based regional bank operating 175 branches and 174 ATMs across Arizona, Colorado, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota.
Great Western Bancorp Inc has a forward price-earnings ratio of 12.67, which derives from Monday’s closing price of $36.12 per share and analyst expectations for earnings of approximately $2.85 per share for the next full fiscal year.
The stock has risen by 57.4% over the past year for a market capitalization of $2.04 billion and a 52-week range of $2.66 to $4.90.
GuruFocus has assigned a rating of 3 out of 10 for the company's financial strength and a rating of 4 out of 10 for its profitability.
Wall Street sell-side analysts recommend a median rating of hold with an average price target of $35.50 per share for this stock.
Endo International PLC
The third stock that makes the cut is Endo International PLC (ENDP, Financial), a generic and branded drug manufacturer in the U.S. and internationally.
Endo International PLC has a forward price-earnings ratio of 12.18, which derives from Monday’s closing price of $6.70 per share and analyst expectations for earnings of approximately $0.55 per share for the next full fiscal year.
The stock has risen by 27.38% over the past year for a market capitalization of $1.57 billion and a 52-week range of $1.93 to $10.89.
GuruFocus has assigned a rating of 2 out of 10 for the company's financial strength and a rating of 5 out of 10 for its profitability.
Wall Street sell-side analysts recommend a median rating of hold and have established an average price target of $6.86 per share for the stock.
Become a Premium Member to See This: (Free Trial):